A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
IDEAYA Biosciences
A2 Biotherapeutics Inc.
University Hospital Southampton NHS Foundation Trust
Eye & ENT Hospital of Fudan University
Fundació Sant Joan de Déu
Incyte Corporation
Barbara Ann Karmanos Cancer Institute
Emory University
Sanofi
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium